COVID-19流行期间创伤后应激障碍的患病率及危险因素

2021-12-01 小文子 MedSci原创

COVID-19流行期间,护士PTSD的患病率较高。

COVID-19流行对个体心理健康产生负面影响。研究发现,创伤后应激障碍(PTSD)、抑郁和焦虑是流行病爆发最常见的心理健康问题。发表在International Journal of Nursing Studies杂志的一项研究探索了COVID-19患者/幸存者、卫生专业人员和一般人群中PTSD的全球患病率和相关危险因素。

研究检索了数据库COVID-19流行期间创伤后应激障碍相关文献,数据分析采用logit变换随机效应模型。根据人群暴露模型分为三组:患者/幸存者、卫生专业人员和一般人群。采用了Peter法评估纳入研究中潜在的发表偏倚。

检索到4045项研究,最终纳入24个不同国家的63项研究(n=124952)。PTSD患病率的总体综合估计值为17.52%(95%CI, 13.89%-21.86%),没有发表偏倚(t=-0.22,p=0.83)。研究发现,COVID-19患者(15.45%; 95%CI, 10.59-21.99),卫生专业人员(17.23%;95% CI, 11.78-24.50)和一般人群(17.34%;95%CI, 12.21-24.03)的PTSD患病率较高。亚组分析显示,COVID-19病房医务人员(30.98%;95%CI, 16.85-49.86),护士(28.22%;95%CI, 15.83-45.10),医生(10.80%, 95%CI, 6.12-18.38),其他医务人员(7.69%, 95%CI, 4.42-12.19),欧洲(25.05%; 95%CI, 19.14-32.06),亚洲(15.50%, 95%CI, 11.29-20.92),以及使用PTSD量表(DSM-5)(30.18%; 95% CI, 25.78-34.98)的PTSD患病率较高。回归分析显示,65岁以上老年人PTSD患病率低于成年人群(-1.75; 95%CI, -3.16 ~ -0.34)。

结果显示,COVID-19患者、卫生专业人员和一般人群的PTSD患病率较高。年龄、工作单位、卫生专业人员、区域和PTSD评估工具是重要的调节变量。对于因COVID-19导致的PTSD患者需要进一步的心理支持。

原文出处:

Ninik Yunitri, Hsin Chu, et al, Global prevalence and associated risk factors of posttraumatic stress disorder during COVID-19 pandemic: A meta-analysis, International Journal of Nursing Studies, 2021, https://doi.org/10.1016/j.ijnurstu.2021.104136.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1250781, encodeId=0bc51250e81d4, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri Dec 03 04:05:54 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335377, encodeId=461713353e7a0, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Fri Dec 03 04:05:54 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445364, encodeId=d7b71445364e6, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79df5138909, createdName=ms1260584454294838, createdTime=Fri Dec 03 04:05:54 CST 2021, time=2021-12-03, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1250781, encodeId=0bc51250e81d4, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri Dec 03 04:05:54 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335377, encodeId=461713353e7a0, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Fri Dec 03 04:05:54 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445364, encodeId=d7b71445364e6, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79df5138909, createdName=ms1260584454294838, createdTime=Fri Dec 03 04:05:54 CST 2021, time=2021-12-03, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1250781, encodeId=0bc51250e81d4, content=<a href='/topic/show?id=7d6f52988e1' target=_blank style='color:#2F92EE;'>#患病率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52988, encryptionId=7d6f52988e1, topicName=患病率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Fri Dec 03 04:05:54 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1335377, encodeId=461713353e7a0, content=<a href='/topic/show?id=e7cc32022c7' target=_blank style='color:#2F92EE;'>#创伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32022, encryptionId=e7cc32022c7, topicName=创伤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aa5a2500103, createdName=ms920641618706883, createdTime=Fri Dec 03 04:05:54 CST 2021, time=2021-12-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1445364, encodeId=d7b71445364e6, content=<a href='/topic/show?id=61e74928629' target=_blank style='color:#2F92EE;'>#应激#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49286, encryptionId=61e74928629, topicName=应激)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=79df5138909, createdName=ms1260584454294838, createdTime=Fri Dec 03 04:05:54 CST 2021, time=2021-12-03, status=1, ipAttribution=)]

相关资讯

JCC: COVID-19对炎症性肠病患者的结果和长期影响

新型冠状病毒肺炎(Corona Virus Disease 2019,COVID-19),简称“新冠肺炎”,世界卫生组织命名为“2019冠状病毒病”,是指2019新型冠状病毒感染导致的肺炎。

J Allergy Clin Immunol Pract:过敏性鼻炎和哮喘对COVID-19感染、住院和死亡率的影响

调查了AR和/或哮喘在COVID-19感染、严重程度和死亡率中的影响,并评估了长期服用AR和/或哮喘药物是否影响COVID-19的结果。

Heart:“神药”阿司匹林在COVID-19期间是否还是“无敌”?

“神药”对COVID-19大流行期间的保护作用有待进一步论证。

Nat Med:使用可穿戴数据对COVID-19实时预警

这项研究表明,实时警报系统可用于早期检测感染和其他应激源,且该警报系统可扩展到拥有数百万用户的开源平台上进行使用。

Radiology:对于新冠病毒感染后仍有症状的患者,心脏MRI会给我们什么提示?

着2019年冠状病毒病(COVID-19)的大流行,科学研究的数量以及我们对新型严重急性呼吸道综合征冠状病毒2的了解也在稳步增加。

结核病与COVID-19合并感染全球负担

TB可能是重度COVID-19的危险因素。